| Tretinoin | Approved Investigational Nutraceutical | TNFSF15 | 9966 |
upregulated | Tretinoin results in increased expression of TNFSF15 mRNA | 9q32 | |
| Tretinoin | Approved Investigational Nutraceutical | TNFSF4 | 7292 |
upregulated | Tretinoin results in increased expression of TNFSF4 mRNA | 1q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TNNI3 | 7137 |
downregulated | Tretinoin results in decreased expression of TNNI3 mRNA | 19q13.4 | |
| Tretinoin | Approved Investigational Nutraceutical | TNNT1 | 7138 |
downregulated | Tretinoin results in decreased expression of TNNT1 mRNA | 19q13.4 | |
| Tretinoin | Approved Investigational Nutraceutical | TNNT2 | 7139 |
downregulated | Tretinoin results in decreased expression of TNNT2 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TNPO2 | 30000 |
downregulated | Tretinoin results in decreased expression of TNPO2 mRNA | 19p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | TNS3 | 64759 |
upregulated | Tretinoin results in increased expression of TNS3 mRNA | 7p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TNS4 | 84951 |
downregulated | Tretinoin results in decreased expression of TNS4 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TNXA | 7146 |
upregulated | Tretinoin results in increased expression of TNXA mRNA | 6p21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | TOB2P1 | 222699 |
upregulated | Tretinoin results in increased expression of TOB2P1 mRNA | 6p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TOE1 | 114034 |
downregulated | Tretinoin results in decreased expression of TOE1 mRNA | 1p34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TOM1L1 | 10040 |
downregulated | Tretinoin results in decreased expression of TOM1L1 mRNA | 17q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TOM1L2 | 146691 |
upregulated | Tretinoin results in increased expression of TOM1L2 mRNA | 17p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TOP1 | 7150 |
downregulated | Tretinoin results in decreased expression of TOP1 mRNA | 20q12 | |
| Tretinoin | Approved Investigational Nutraceutical | TOP2A | 7153 |
downregulated | Tretinoin results in decreased expression of TOP2A mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TOP2B | 7155 |
downregulated | Tretinoin results in decreased expression of TOP2B mRNA | 3p24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | TOR1B | 27348 |
upregulated | Tretinoin results in increased expression of TOR1B mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | TOX | 9760 |
downregulated | Tretinoin results in decreased expression of TOX mRNA | 8q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TOX3 | 27324 |
downregulated | Tretinoin results in decreased expression of TOX3 mRNA | 16q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TP53 | 7157 |
upregulated | Tretinoin results in increased expression of TP53 mRNA | 17p13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TP53I3 | 9540 |
upregulated | Tretinoin results in increased expression of TP53I3 mRNA | 2p23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | TP53INP1 | 94241 |
upregulated | Tretinoin results in increased expression of TP53INP1 mRNA | 8q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TP53TG1 | 11257 |
upregulated | Tretinoin results in increased expression of TP53TG1 mRNA | 7q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | TPBG | 7162 |
downregulated | Tretinoin results in decreased expression of TPBG mRNA | 6q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | TPBG | 7162 |
upregulated | Tretinoin results in increased expression of TPBG mRNA | 6q14.1 | |